AHA: Rivaroxaban Drops Pro-Coagulation Factor in HF Patients (CME/CE)

ORLANDO (MedPage Today) Biomarkers of hypercoagulability an ominous sign in patients with heart failure appear to be reduced by treatment with the oral, direct Factor Xa inhibitor rivaroxaban, a researcher said at the AHA meeting here.

source : www.medpagetoday.com

Related News:

• QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
• Clinic Closure Leaves Indigent Dialysis Patients Looking For Treatment
• Study Finds Some Vegetative Patients Show Awareness, Raising Ethical Questions
• Fat Behaves Differently In Patients With Polycistic Ovary Syndrome
• Cedars-Sinai Researchers: Fat Behaves Differently In Patients With Polycistic Ovary Syndrome
• Identification Of Brain Protein For Synapse Development
• Study Finds Reduced Brain Gray Matter Concentration In Patients With Severe Obstructive Sleep Apnea
• Study Published In The American Journal Of Ophthalmology Examines Investigational Use Of Macugen In Patients With Branch Retinal Vein Occlusion
• RA Patients Maintain Computer Skills (CME/CE)
• ‘Silent Strokes’ Linked To Kidney Failure In Diabetics

Details :
Submited at Monday, November 16th, 2009 at 1:00 am on Cardiology by Alina
Comment RSS 2.0 - leave a comment - trackback